Charles Duncan Analyst PerformanceManaging Director & Senior Research Analyst at Cantor FitzgeraldCharles Duncan is a stock analyst at Cantor Fitzgerald focused in the healthcare sector, covering 59 publicly traded companies. Over the past year, Charles Duncan has issued 2 stock ratings, including and buy recommendations. While full access to Charles Duncan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Charles Duncan's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings294 Last 12 YearsBuy Recommendations85.12% 246 Buy RatingsCompanies Covered59 Unique Companies Ratings Distribution289RatingsDistribution of strong buy, buy, hold, and sell ratings by Charles Duncan.RatingPercentageCount Strong Buy0.0%0 ratings Buy85.1%246 ratings Hold14.5%42 ratings Sell0.3%1 ratingsOut of 289 total stock ratings issued by Charles Duncan at Cantor Fitzgerald, the majority (85.1%) have been Buy recommendations, followed by 14.5% Hold and 0.3% Sell.Best & Worst CallsBest Call000000.0%AXSMDec 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NVAXMar 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ89.8% of companies on NASDAQ53 companiesTSE3.4% of companies on TSE2 companiesOTCMKTS3.4% of companies on OTCMKTS2 companiesNYSE1.7% of companies on NYSE1 companyNYSEAMERICAN1.7% of companies on NYSEAMERICAN1 companyCharles Duncan, an analyst at Cantor Fitzgerald, currently covers 59 companies listed on NASDAQ, TSE, OTCMKTS, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare58 companies98.3%Industrials1 company1.7%Charles Duncan of Cantor Fitzgerald specializes in stock coverage within the Healthcare sector, with additional focus on Industrials companies.Coverage IndustriesIndustryPercentagePHARMACEUTICALS28 companies47.5%BIOTECHNOLOGY26 companies44.1%HEALTHCARE EQUIPMENT & SUPPLIES2 companies3.4%LIFE SCIENCES TOOLS & SERVICES1 company1.7%HEALTHCARE PROVIDERS & SERVICES1 company1.7%AEROSPACE & DEFENSE1 company1.7% About Charles DuncanCharles has >25 years of sell-side experience, and is a Managing Director and senior biotechnology research analyst at Cantor Fitzgerald. From late 2012 and until early July 2018 he was a Managing Director and senior biotech analyst at Piper Jaffray & Co. Previously he was a founding partner of JMP Securities healthcare group and served as an analyst with that firm since 2002. He has also been a publishing analyst at Dresdner Kleinwort Wasserstein, Vector Healthcare Group - Prudential Securities, Tucker Anthony Cleary Gull and Chatfield Dean & Co. Duncan has been recognized by industry sources, including the StarMine Analyst Awards, as being among the best analysts for his fundamental and timely analysis. Additionally Charles has achieved Tip Ranks ranking that places him in the top 5% of all analysts and above the majority of other senior biotech analysts.Follow on LinkedIn Charles Duncan's Ratings History at Cantor Fitzgerald Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGHRSGH Research8/7/2026Boost Price Target$30.64$40.00Overweight$0.0000.00% ROIGHRSGH Research5/15/2026Boost Price Target$22.21$35.00Overweight$0.0000.00% ROISLDBSolid Biosciences7/21/2025Set Price Target$6.73$16.00Overweight$0.0000.00% ROICMPSCompass Pathways3/28/2025Reiterated Rating$3.03Overweight$0.0000.00% ROIACADACADIA Pharmaceuticals2/27/2025Reiterated Rating$20.24$28.00Overweight$00.0000.00% ROIJAZZJazz Pharmaceuticals2/26/2025Downgrade$144.60$150.00Neutral$000.0000.00% ROIAXSMAxsome Therapeutics2/19/2025Reiterated Rating$127.42$153.00Overweight$000.0000.00% ROIGHRSGH Research2/13/2025Initiated Coverage$14.00$14.00Overweight$00.0000.00% ROIDRUGBright Minds Biosciences1/10/2025Initiated Coverage$41.04Overweight$00.0000.00% ROIVYGRVoyager Therapeutics1/10/2025Initiated Coverage$5.60$5.73Overweight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
